IFPMA 2015 interview series ‘The threat of counterfeit medicines’
Ms Cyntia Genolet is IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio. In this short interview, she gives a brief summary about the threat posed by counterfeit medicines and factors encouraging the trade of counterfeit medicines.
In 2015, IFPMA is organising two workshops on counterfeit medicines in Asia and Africa.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.Learn more
Media ContactAbigail Jones firstname.lastname@example.org